Broxil (BRL 152), the potassium salt of 6-(x phenoxyproprionamide)-penicillanic acid (Phenethicillin) when given orally, is claimed to give penicillin blood levels two or three times as high as those obtained by penicillin V, and at least equal to those obtained by intramuscular injections of penicillin G. A trial of this drug in the treatment of gonorrhoea in male patients was started in November, 1959.
Material
The patients treated with Broxil were taken from those attending the clinic at St. Mary's Hospital London, with acute gonococcal urethritis, both first attacks and re-infections. We excluded those about to leave the district and therefore unable to attend for routine follow-up, a small number with complications of gonorrhoea (e.g. epididymitis), those with genital ulceration, and those who gave a definite history of penicillin sensitivity.
Dosage
At first, a single dose of 1,000 mg. (four 250-mg. tablets) was used. However, after the treatment of only five cases with this dosage, it became obvious that a divided dosage would be advisable. Two of the first five patients developed symptoms of acute indigestion soon after taking the tablets, followed, on the next day, by "black diarrhoea" presumably due to acute gastric irritation. Three of them were cured of their gonorrhoea but the other two failed to respond.
This dosage schedule was therefore abandoned and the next hundred patients were given two doses, each of 500 mg. The first dose (two 250-mg. tablets) was given at the clinic and two more tablets were to be taken by the patient after a specified interval. With this arrangement, there were no complaints of any illeffects. We had been advised that the drug should be given, as far as possible, on an empty stomach and this was attempted in earlier cases but was given up owing to practical difficulties. There was no apparent deterioration in effect as a result of this change.
The first sixty patients were given 500 mg. (two tablets) on the first visit to the clinic and were instructed to take a further two tablets after 8 hours. The remaining forty patients were told to take the second dose after 4 hours.
Results
Of the 100 patients treated with the divided dosage, twelve failed to respond and were re-treated by other means. The proportion of failures in racial groups was as follows:
Of the apparently successful cases, about one-third remained under observation for from 1 to 3 weeks, one-third for less than 1 week, and one-third failed to return for any follow-up at all.
Although this is obviously very unsatisfactory in assessing the results of treatment, we have found, over the years, that many of our patients, particularly West Indians, will return to the clinic only if any urethral symptoms persist. Their Shiel (1956) treated 28 males with oral penicillin V; 25 had 3 -6 mega units -in divided doses over 3 days; two had 1-2 mega units in 1 day; and one had 2 4 mega units over 2 days. There was only one failure, and that was believed to have been a re-infection.
A matter for consideration is the difficulty of accurate identification of a treatment failure as opposed to a re-infection. In almost every case, in the treatment of out-patients, this differentiation depends entirely on a truthful history from the patient.
New cases of gonorrhoea attending this clinic are at present almost equally divided between white and coloured patients, but 65 per cent. of the admitted re-infections occur in coloured patients.
The difference in treatment failure rates between white and coloured patients recorded above (9 3 per cent. coloured, 3 9 per cent. white) suggests that one factor may be the inaccurate histories given by some of the coloured patients.
It is worth noting that some of the "treatment failures" among our coloured patients occurred in the most promiscuous or least intelligent (often both!), organisms cultured from these "treatment failures" seldom showing any degree of insensitivity to penicillin. 
